A carregar...
SUN-388 Immune Checkpoint Inhibitor Nivolumab in Advanced or Recurrent Adrenocortical Carcinoma
Introduction: Adrenocortical carcinoma (ACC) is a rare and highly aggressive malignancy. Due to the rarity of this malignancy, controlled trials investigating efficacy of chemotherapy or immunotherapy are uncommon. Newer therapy with immune check point inhibitor Nivolumab, a monoclonal antibody of t...
Na minha lista:
| Publicado no: | J Endocr Soc |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553290/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-388 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|